132
Participants
Start Date
June 10, 2014
Primary Completion Date
April 30, 2016
Study Completion Date
October 22, 2018
Abemaciclib
Administered orally
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Brussels
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leuven
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Liège
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Charleroi
Memorial Sloan Kettering Cancer Center, New York
Washington Hospital Center, Washington D.C.
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dijon
Maryland Oncology Hematology, P.A., Columbia
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madrid
Advanced Medical Specialties, Miami
Florida Cancer Specialists, St. Petersburg
Florida Cancer Specialists, Fort Myers
Sarah Cannon Research Institute SCRI, Nashville
Oncology Hematology Care Inc, Cincinnati
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Valencia
Minnesota Oncology/Hematology PA, Minneapolis
Texas Oncology-Plano West, Plano
Presbyterian Hospital Dallas, Dallas
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Paris
Tyler Cancer Center, Tyler
Texas Oncology - Bedford, Bedford
The Center for Cancer and Blood Disorders, Fort Worth
Texas Oncology-Memorial City, Houston
US Oncology, The Woodlands
Texas Oncology Cancer Center, Austin
Rocky Mountain Cancer Center, Denver
HOPE Hematology Oncology Physicians and Extenders, Tucson
Arizona Clinical Research Center, Tucson
Northern Arizona Hematology & Oncology Associates, Sedona
Sansum Medical Research Foundation, Santa Barbara
Univ of California San Francisco, San Francisco
Northwest Cancer Specialists PC, Vancouver
Dana Farber Cancer Institute, Boston
Texas Oncology-Sherman, Sherman
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Barcelona
Eli Lilly and Company
INDUSTRY